Reuters logo
BRIEF-Applied Genetic Technologies reports Q4 revenue of $8.3 mln
2017年9月13日 / 中午11点51分 / 2 个月前

BRIEF-Applied Genetic Technologies reports Q4 revenue of $8.3 mln

Sept 13 (Reuters) - Applied Genetic Technologies Corp :

* Q4 revenue $8.3 million versus $12.1 million

* Q4 revenue view $11.9 million -- Thomson Reuters I/B/E/S

* Q4 ‍loss per share $0.18​

* Q4 earnings per share view $0.06 -- Thomson Reuters I/B/E/S

* Expected to initiate patient enrollment in XLRP program in Q1 of 2018

* Co believes its cash, cash equivalents, investments as of June 30 to be sufficient to fund planned programs for at least the next 2 years Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below